학술지 개제논문

SCI 등재 학술지에 게재된 논문 (2012 ~ 2011)

191. Nakanuma Y, Sato Y, Ikeda H, Harada K, Kobayashi M, Sano K, Uehara T, Yamamoto M, Ariizumi S, Park YN, Choi JH, Yu E: Intrahepatic cholangiocarcinoma with predominant "ductal plate malformation" pattern: a new subtype. Am J Surg Pathol 2012, 36:1629-1635.
190. Lee CR, Lim JH, Kim SH, Ahn SH, Park YN, Choi GH, Choi JS, Kim KS: A comparative analysis of hepatocellular carcinoma after hepatic resection in young versus elderly patients. J Gastrointest Surg 2012, 16:1736-1743.
189. Kim SU, Oh HJ, Wanless IR, Lee S, Han KH, Park YN: The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis. J Hepatol 2012, 57:556-563.
187. Kim SU, Lee JH, Kim DY, Ahn SH, Jung KS, Choi EH, Park YN, Han KH, Chon CY, Park JY: Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis. PLoS One 2012, 7:e36676.
186. Kim SU, Kim JK, Park YN, Han KH: Discordance between liver biopsy and Fibroscan(R) in assessing liver fibrosis in chronic hepatitis b: risk factors and influence of necroinflammation. PLoS One 2012, 7:e32233.
185. Kim JY, Kim MJ, Kim KA, Jeong HT, Park YN: Hyperintense HCC on hepatobiliary phase images of gadoxetic acid-enhanced MRI: correlation with clinical and pathological features. Eur J Radiol 2012, 81:3877-3882.
184. Kim BK, Park YN, Kim DY, Park JY, Chon CY, Han KH, Ahn SH: Risk assessment of development of hepatic decompensation in histologically proven hepatitis B viral cirrhosis using liver stiffness measurement. Digestion 2012, 85:219-227.
183. Kim BK, Kim SU, Kim HS, Park JY, Ahn SH, Chon CY, Cho IR, Joh DH, Park YN, Han KH, Kim DY: Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B. PLoS One 2012, 7:e35825.
182. Kim BK, Kim HS, Park JY, Kim DY, Ahn SH, Chon CY, Park YN, Han KH, Kim SU: Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B. PLoS One 2012, 7:e41964.
181. Jung KS, Park KH, Chon YE, Lee SR, Park YN, Lee DY, Seong JS, Park JY: A case of isolated metastatic hepatocellular carcinoma arising from the pelvic bone. Korean J Hepatol 2012, 18:89-93.
180. Jung KS, Kim SU, Choi GH, Park JY, Park YN, Kim DY, Ahn SH, Chon CY, Kim KS, Choi EH, Choi JS, Han KH: Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan(R)). Ann Surg Oncol 2012, 19:4278-4286.
179. Dang HW, Kim SU, Park JY, Ahn SH, Han KH, Chon CY, Park YN, Choi EH, Kim DY: How many valid measurements are necessary to assess liver fibrosis using FibroScan(R) in patients with chronic viral hepatitis? An analysis of subjects with at least 10 valid measurements. Yonsei Med J 2012, 53:337-345.
178. Cho HJ, Kim SS, Ahn SJ, Bae CB, Kim HG, Kim YJ, Lee SK, Song GW, Kim DJ, Hwang SG, Yang JM, Kim YB, Park YN, Cho SW, Cheong JY: Serum markers for predicting significant necroinflammatory activity in patients with chronic hepatitis B. Clin Biochem 2012, 45:1564-1567.
177. Cheong JY, Um SH, Seo YS, Shin SS, Park RW, Kim DJ, Hwang SG, Lee YJ, Cho M, Yang JM, Kim YB, Park YN, Cho SW: A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis. Hepatogastroenterology 2012, 59:2592-2597.
176. Augello C, Vaira V, Caruso L, Destro A, Maggioni M, Park YN, Montorsi M, Santambrogio R, Roncalli M, Bosari S: MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma. Liver Int 2012, 32:772-782.
175. Rhee H, Kim MJ, Park YN, Choi JS, Kim KS. Gadoxetic acid-enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteria.J MagnReson Imaging. 2012 Feb;35(2):393-8.
174. Kim JK, Chon NR, Lim HC, Lee KS, Han KH, Chon CY, Park YN, Paik YH. Transitional features of histologic type of non-alcoholic fatty liver disease in Korean young men. J GastroenterolHepatol. 2012 Jan;27(1):142-8
173. Seok JY, Na DC, Woo HG, Roncalli M, Kwon SM, Yoo JE, Ahn EY, Kim GI, Choi JS, Kim YB, Park YN: A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition. Hepatology 2012, 55:1776-1786.
[Epub ahead of print]
172. Kim MJ, Lee M, Choi JY, Park YN: Imaging features of small hepatocellular carcinomas with microvascular invasion on gadoxetic acid-enhanced MR imaging. Eur J Radiol 2012, 81:2507-2512.
171. Shin NY, Kim MJ, Lim JS, Park MS, Chung YE, Choi JY, Kim KW, Park YN: Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases. Eur Radiol 2012, 22:864-871.
  170. Kim SM, Leem SH, Chu IS, Park YY, Kim SC, Kim SB, Park ES, Lim JY, Heo J, Kim YJ, Kim DG, Kaseb A, Park YN, Wang XW, Thorgeirsson SS, Lee JS: Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma. Hepatology 2012, 55:1443-1452.  
  169. Jeong HT, Kim MJ, Kim YE, Park YN, Choi GH, Choi JS: MRI features of hepatocellular carcinoma expressing progenitor cell markers. Liver Int 2012, 32:430-440.  
  168. Jung IH, Jung DE, Park YN, Song SY, Park SW. Aberrant hedgehog ligands induce progressive pancreatic fibrosis by paracrine activation of myofibroblasts and ductular cells in transgenic zebrafish. PLoS One. 2011;6(12):e27941. Epub 2011 Dec 2.  
  167. Kim H, Choi GH, Na DC, Ahn EY, Kim GI, Lee JE, Cho JY, Yoo JE, Choi JS, Park YNHuman hepatocellular carcinomas with
'stemness’-related marker expression: keratin 19 expression and a poor prognosis. HEPATOLOGY 2011;54:1707-1717
  166. Yoon H, Lee H, Kim HJ, You KT, Park YN, Kim H, Kim H. Tudor domain-containing protein 4 as a potential cancer/testis antigen in liver cancer. Tohoku J Exp Med. 2011;224(1):41-6.  
  165. Suh YJ, Kim MJ, Choi JY, Park YN, Park MS, Kim KW. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI. AJR Am J Roentgenol. 2011 Jul;197(1):W44-52.  
  164. Lee SM, Park H, Choi JW, Park YN, Yun CO, Yoo KH. Multifunctional nanoparticles for targeted chemophotothermal treatment of cancer cells.AngewChemInt Ed Engl. 2011 Aug 8;50(33):7581-6.  
  163. Choi JY, Kim MJ, Park YN, Lee JM, Yoo SK, Rha SY, Seok JY. Gadoxetate disodium-enhanced hepatobiliary phase MRI of hepatocellular carcinoma: correlation with histological characteristics. AJR Am J Roentgenol. 2011 Aug;197(2):399-405.  
  162. Cheong JY, Kim DJ, Hwang SG, Yang JM, Kim YB, Park YN, Cho SW. Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels. Liver Int. 2011 Oct;31(9):1352-8  
  161. Jung KS, Kim SU, Ahn SH, Park YN, Kim do Y, Park JY, Chon CY, Choi EH, Han KH. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology. 2011 Mar;53(3):885-94.  
  160. Shin E, Lee KB, Park SY, Kim SH, Ryu HS, Park YN, Yu E, Jang JJ.Gene expression profiling of human hepatoblastoma using archived formalin-fixed and paraffin-embedded tissues. Virchows Arch. 2011 Apr;458(4):453-65.  
  159. Choi GH, Park JY, Hwang HK, Kim DH, Kang CM, Choi JS, Park YN, Kim do Y, Ahn SH, Han KH, Chon CY, Lee WJ. Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma. Liver Int. 2011 Apr;31(4):485-93.  
  158. Cho JY, Lim JY, Cheong JH, Park YY, Yoon SL, Kim SM, Kim SB, Kim H, Hong SW, Park YN, Noh SH, Park ES, Chu IS, Hong WK, Ajani JA, Lee JS. Gene expression signature-based prognostic risk score in gastric cancer. Clin Cancer Res. 2011 Apr 1;17(7):1850-7.  
  157. Hyun SY, Lee JH, Shin HS, Lee SW, Park YN, Park JY. Cutaneous metastasis from cholangiocarcinoma as the first clinical sign: a report of two cases. Gut Liver. 2011 Mar;5(1):100-4.  
  156. Lim SO, Park YM, Kim HS, Quan X, Yoo JE, Park YN, Choi GH, Jung G. Notch1 differentially regulates oncogenesis by wildtype p53 overexpression and p53 mutation in grade III hepatocellular carcinoma. Hepatology. 2011 Apr;53(4):1352-62.  
  155. Lee MJ, Kim MJ, Yoon CS, Han SJ, Park YN. Evaluation of liver fibrosis with T2 relaxation time in infants with cholestasis: comparison with normal controls. PediatrRadiol. 2011 Mar;41(3):350-4.  
  154. Choi KK, Hong YJ, Choi SB, Park YN, Choi JS, Lee WJ, Kim KS. Hepatocellular carcinoma during pregnancy: is hepatocellular carcinoma more aggressive in pregnant patients? J HepatobiliaryPancreat Sci. 2011 May;18(3):422-31. HEPATOLOGY 2011;54:1707-1717  
  153. Cheong JY, Um SH, Seo YS, Kim DJ, Hwang SG, Lee YJ, Cho M, Yang JM, Kim YB, Park YN, Cho SW. Non-Invasive Index for Predicting Significant Liver Fibrosis: Comparison of Diagnostic Performances in Patients with Chronic Hepatitis B and C. Dig Dis Sci. 2011 Feb;56(2):555-63.  
  152. Choi SB, Kim H, Kim SH, Park YN, Kim KS. Solitary extrahepaticintraabdominal metastasis from hepatocellular carcinoma after liver transplantation.Yonsei Med J. 2011 Jan 1;52(1):199-203  
  151. Kim SU, Jang HW, Cheong JY, Kim JK, Lee MH, Kim DJ, Yang JM, Cho SW, Lee KS, Choi EH, Park YN, Han KH. The usefulness of liver stiffness measurement using FibroScan in chronic hepatitis C in South Korea: a multicenter, prospective study. J GastroenterolHepatol. 2011 Jan;26(1):171-8.  
  150. Hong YK, Choi SB, Lee KH, Park SW, Park YN, Choi JS, Lee WJ, Chung JB, Kim KS. The efficacy of portal vein embolization prior to right extended hemihepatectomy for hilarcholangiocellular carcinoma: A retrospective cohort study.Eur J SurgOncol. 2011 Mar;37(3):237-44.  
  149. Park YN, Kim MJ. Hepatocarcinogenesis: imaging-pathologic correlation. Abdom Imaging. 2011 Jun;36(3):232-43.  
  148. Park YN. Update on precursor and early lesions of HCC. Arch Pathol Lab Med  2011 Jun;135(6):704-15.  
  147. Yoon SM, Gerasimidou D, Kuwahara R, Hytiroglou P, Yoo JE, Park YN, Theise ND. Epithelial Cell Adhesion Molecule
(EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans. Hepatology. 2011:53(3):964-73.
  146. Na DC, Lee JE, Yoo JE, Oh BK, Choi GH, Park YN. Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study. ExpMolPathol. 2011 Feb;90(1):66-73  
  145. Oh BK, Um TH, Choi GH, Park YN. Frequent changes in subtelomeric DNA methylation patterns and its relevance to telomere regulation during human hepatocarcinogenesis.Int J Cancer. 2011 Feb 15;128(4):857-68.  
  144. Um T-H, Kim H, Oh B-K, Kim MS, Kim KS, Jung G, Park YN. Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis. J Hepatol 2011; 54: 939?947